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Introduction
The pathological identity of lymphangioma is still controversial, 
though it is now generally expressed as a disease of congenital venous 
and lymphatic malformations (1). The predilection sites are neck, 
axilla and mediastinum (2), usually developed in the soft tissue of 
those regions. Primary bone lymphangioma is very rare. Since the 
first description by Bickel and Broders in 1947, less than 30 bone 
Öz
Kalvaryal kavernöz lenfanjiom çok az sayıda yayında bildirilmiş ve son derece 
nadir rastlanan bir klinik antitedir. Lenfanjiomlar vücudun birçok yerinde görülse 
de lenfanjiomlarla sıklıkla boyun ve uzun kemiklerde karşılaşılır ve literatürde 
lenfanjiomların birçok tipi tanımlanmıştır. Lenfanjiomlar için birçok tedavi seçeneği 
tanımlansa da lokal nüks hala büyük bir problemdir. Pediatrik popülasyonda 
kafatası defektleri sıklıkla kraniyoplasti gerektirir. Allogreft veya otolog kemik 
greftleri kraniyoplasti için bir seçenektir. Dört aylık erkek bir hasta, kraniyal 
bilgisayarlı tomografide kalvaryal veya ekstrakraniyal dış kabuğu kalsifiye bir lezyon 
görünümünde, ağrısız bir kitlesel lezyon nedeniyle hospitalize edildi. Hastaya cerrahi 
rezeksiyon uygulandı ve patoloji ile kavernöz lenfanjiom tanısı doğrulandı. Biz bu 
olguyu görüntüleme bulguları ve mevcut literatürün değerlendirilmesi ile sunuyoruz.
Calvarial cavernous lymphangioma is an extremely rare disease entity with only a 
few reports. Lymphangiomas are frequently encountered neck and long bone but it 
may also seen in many part of the body and many tips of the lymphangioma have 
been identified. Several treatment options have been defined but local recurrence 
is still a big problem. In the pediatric population, postoperative skull defects may 
frequently require cranioplasty. Allografts or autologous bone grafts may be used 
for cranioplasty. A four-month-old male patient was hospitalized due to a painless 
head mass, which was revealed as a soft tissue lesion located in calvarial diploe or 
extracranial lesion with outer calcified shell on the cranial computed tomography. 
The patient underwent surgical resection, pathologically confirmed as cavernous 
lymphangioma. We report this case with imaging findings and review of literatures.
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lymphangiomas have been reported (3). Especially, 
skull lymphangioma is extremely rare. It has been 
reported in only a few literatures (4), describing as 
an asymptomatic head lump incidentally detected or 
lump presenting with pain (5). We report a case of a 
four-month-old male patient who presented a skull 
mass confirmed as a cavernous lymphangioma. 
Case Report
A four-month-old male patient referred to the 
hospital due to abnormal bulging of the left parietal 
area in the head. He had a normal neurological 
examination. However, skull X-ray series showed 
mass like lesion with sclerotic rim in the left parietal 
bone area (Figure 1). Cranial computed tomography 
(CT) was subsequently performed, revealing mixed 
density crescent shape lesion developed in diploe, 
separating inner and outer table of the skull. There 
were no abnormal findings in the brain (Figure 2). 
Approval forms were taken from parents of child. After 
preoperative preparations patient underwent surgical 
resection to remove the lesion. Thin purple colored 
calvarial bone covered the lesion under the scalp. After 
the removal of this thin bony layer, yellowish-white 
soft tissue mass was exposed. It contained brownish 
fluid loculation inside (Figure 3). All abnormal lesions 
including mass and surrounding bones were totally 
removed. Inner table of the calvarium was clear 
without involvement of the lesion. 
Pathologic examination showed proliferation 
of the enlarged lymphatics with destructed bony 
trabeculae in some areas. Immunohistochemical 
studies revealed positive staining of CD31+ and 
CD34+. The pathological diagnosis was calvarial 
cavernous lymphangioma (Figure 4). 
Follow-up cranial CT acquired in 6 months, which 
showed remodeling skull around operation site with 
complete filling up in postoperative defect. Residual 
or recurred lesions were not demonstrated. Follow-
up CT in 1 year also showed same findings (Figure 5).
Figure 1. Skull anteroposterior view shows a bulging shadow 
with sclerotic rim in the left parietal area
Figure 3. Intraoperative view of the lesion, after removing 
outer table of the skull
Figure 2. Crescent shape lesion looking like composed of solid 
and cystic portions is seen in the left parietal area. It seems to 
be the lesion developed in diploe, separating inner and outer 
table of the skull or the lesion developed in extracranial area 
with outer calcified shell
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Discussion
Lymphangiomas are uncommon congenital 
tumors, usually discovered in neck and head. The 
cases in the literature are generally the ones with 
skeletal expanding (6). They are histologically benign, 
extruding surrounding normal structures without 
invasion or destruction when they grow in expanding 
pattern. However, lethal complications might be 
caused according to the location and growing behavior 
(7). 
Lymphangiomas are classified into three groups 
as follows: cystic, cavernous and capillary. Cystic 
lymphangioma is formed of dilated thin walled spaces 
surrounded with regularly arranged endothelial cells 
that are full of eosinophilic proteinaceous fluid (3). 
Cavernous lymphangioma consists of large lymphatic 
channels, located inside the bones, soft tissues and 
organs. Capillary lymphangioma is characterized with 
including lymphatic channels in the size of capillaries. 
It is generally located in the skin but some of them 
have been reported to be located in the bone (4). 
The pathogenesis is not obvious yet. Infectious, toxic, 
neoplastic and congenital mechanisms are all thought 
to be possible (8). As the histopathologic sections of 
our case included large lymphatic channels, it has 
been diagnosed as cavernous lymphangioma and any 
predisposing factors could not be found.
Primary lymphangioma involving bone is rare. 
Only small number of cases have been reported 
in previous literatures. According to previous 
reports, bone lymphangiomas were discovered in 
the metaphysis and/or diaphysis of tibia, humerus, 
ilium, skull, mandible, and spine (3,9). Especially 
among them, involvement of skull is extremely rare, 
described just in a few literatures. The symptoms in 
bone lymphangioma is associated with the eroding 
of the bone by the enlargement of the lymphatics 
or the pressure of it. Patients may be presented by 
local pain, enduration or pathologic fractures or it can 
be diagnosed incidentally in the radiologic imagings 
that have been performed for another suspicion (2). 
Radiographs of the skull lymphangioma have been 
described in a few reports. Plain skull series typically 
demonstrate expanding change of calvarial bony 
tables, which might cause loss of bony coverage. CT 
reveals the low lesion associated with mixed lytic and 
sclerotic changes of the skull. Internal hemorrhage 
might be developed, causing changes of imaging 
nature on CT or magnetic resonance imaging (4,10). 
Treatment is aimed for cosmetic or pain control as 
well as curative removal of the lesion. Total surgical 
excision, sclerotherapy and laser ablation have been 
popularly used for the treatment. As lymphangiomas 
have high tendency of local recurrence, total resection 
is known as the best treatment choice (1,3,11,12). 
Sclerotherapy and laser ablation are often used for 
the treatment of soft tissue lymphangiomas. 
Figure 4. Enlarged lymphatic channels are seen with 
erythrocytes inside the lumen (hematoxylin and eosin x100)
Figure 5. Follow-up computed tomography in 1 year shows 
no residual or recurred lesions. Bony defect is not seen in 
operation site
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In the pediatric age, postoperative skull defects 
frequently require cranioplasty. Allografts or 
autologous grafts may be used for cranioplasty, 
although autologous bone graft should be the first 
option in pediatric age. The best donor source of 
autologous bone is referred as a split-thickness 
cranium. But, it is almost impossible to perform the 
procedure because of the thin and immature diploe 
of the skull in children younger than 3 years old. The 
second harvesting area for bone grafts is referred as an 
autologous split rib grafts. But, this procedure requires 
a second wound site and a prolonged operating time. 
In addition, autologous bone grafts can be absorbed 
partially. Allograft materials options for cranioplasty 
are metallic mash plates, methyl methacrylate, 
hydroxyapatite and porous polyethylene with high 
density (13-15). In the different serious, complication 
rate changes between 5% and 30%. Infection is 
the most important problem due to used allograft 
materials after total resection of calvarial mass (14).
In our case, we did not perform cranioplasty or the 
other options. Because his age was not suitable for 
autologous bone grafting and his inner table of the 
calvaria was clear. We thought that new bone might 
develop from his inner table of the calvaria and we 
saw remodeling on his calvarial bone in over time. We 
can ask a question ourselves for self-criticism in here, 
could a local recurrence develop in the surgery area? 
Of course, we could saw a local recurrence because 
recurrence is still a big problem.
We experienced an extremely rare case of skull 
lymphangioma, which was manifested as a soft tissue 
lesion located in calvarial diploe. It was clinically 
presented as abnormal bulging of the skull and total 
surgical resection was achieved without intermediate 
term evidence of local recurrence. Postoperative 
follow-up of lymphangiomas is important because of 
the local recurrence.
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Dear Editor;
Head and neck cancer (HNC) forms 8% of the adult cancers and 
each year approximately 600.000 new cases occur. In the course of 
application, about 40% of the cases are in early stage, 50% is locally 
advanced (stage III and IV) and 10% is in metastatic stage. More than 
90% of the cases are squamous cell carcinoma and alcohol and smoking 
are common etiological factors. Human papillomavirus virus is a risk 
factor especially for oropharyngeal squamous cell carcinoma (1).
The anatomic localization of the disease, the stage of the disease, 
pathological features and the other diseases of the patient (comorbidity) 
are important factors to choose the treatment. Although there is not 
only one approach of treatment, surgical cure and radiotherapy have 
the similar survival results in early stage. For locally advanced cases, 
radiotherapy or concomitant chemoradiotherapy is widely used. In 
concomitant chemoradiotherapy implementations, cisplatin is the gold 
standard treatment. However, the toxicity related with chemotherapy 
(particularly cisplatin) restricts the application of chemoradiotherapy 
with especially the patients who have comorbidity. Epidermal growth 
factor receptor (EGFR) shows abnormal activity in several epithelial 
cancers including HNC. Therefore, there are so many done and ongoing 
studies, which are about different kinds of cancers with the agents 
who target this pathway (2).
Firstly, in the study of Bonner et al. (3) only radiotherapy (RT) and 
cetuximab treatments with RT are compared. In combination arm in 
comparison with only RT, a significantly better local-regional control 
is statistically provided (median 14.9 months against 24.4 months 
and p=0.005). Accordingly, while median survival is 49 months in 
cetuximab and RT arm for overall survival (OS), it has been found 
more superior in combination arm as 29.3 months (p=0.03) in RT arm. 
Place in Concomitant Use with Anti-
EGFR Radiotherapy in Locally Advanced 
Head and Neck Cancer Treatment
